Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HP011-101 (Xenaderm) for Pressure Ulcers in Spinal Cord Injury
NCT01433159Phase 2Terminated
- Sponsor
- Healthpoint Biotherapeutics
- Start
- Sep 2011
- Primary completion
- Jan 2013
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of balsam peru + castor oil + trypsin in pressure ulcer (2 arms), sponsored by Healthpoint Biotherapeutics. Primary endpoint: Pressure Ulcer Scale for Healing Score at 14 days. Started Sep 2011; status: terminated.
02
Drugs
balsam peru + castor oil + trypsin
03
Conditions
pressure ulcer
Beyond the preview
Go deeper on NCT01433159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01433159.